Inactive Instrument

Analyst Reco. Kaleyra, Inc.

Equities

Northland Capital Markets Downgrades Kaleyra to Market Perform From Outperform	23-07-07	MT
Oppenheimer Downgrades Kaleyra to Perform From Outperform on Balance Sheet/Free Cash Flow, Recession Pressures; Removes $2 Price Target	23-03-17	MT
Oppenheimer Adjusts Kaleyra Price Target to $2 From $6, Maintains Outperform Rating	22-11-08	MT
Oppenheimer Adjusts Kaleyra's Price Target to $6 From $10, Maintains Outperform Rating	22-08-09	MT
Oppenheimer Adjusts Kaleyra Price Target to $10 From $17, Maintains Outperform Rating	22-05-10	MT
Craig Hallum Downgrades Kaleyra to Hold From Buy, Lowers Price Target to $6.50 From $15	22-05-10	MT
Maxim Adjusts Kaleyra's Price Target to $27 from $37, Keeps Buy Rating	22-02-17	MT
Oppenheimer Adjusts Kaleyra's Price Target to $17 From $20, Maintains Outperform Rating	22-02-17	MT
KALEYRA : Maxim Adjusts Kaleyra's Price Target to $37 From $42, Maintains Buy Rating	21-08-10	MT
KALEYRA : Oppenheimer Adjusts Kaleyra PT to $20 From $12, Maintains Outperform Rating	21-06-15	MT
KALEYRA : Northland Adjusts Kaleyra's Price Target to $29 From $23, Keeps Outperform Rating	21-06-11	MT
KALEYRA : Craig-Hallum Adjusts Kaleyra's Price Target to $25 From $20, Maintains Buy Rating	21-02-17	MT
KALEYRA : Maxim Starts Kaleyra at Buy With $22 Price Target	21-02-05	MT

No results for this search